1.A clinical study of congenital hypertrophic pyloric stenosis.
Journal of the Korean Surgical Society 1991;41(3):306-313
No abstract available.
Pyloric Stenosis, Hypertrophic*
2.Congenital Middle Ear Cholesteatoma.
Sung Won KIM ; Min Kyo JUNG ; Yong Sig KWUN ; Jun Myung KANG ; Ki Hong CHANG ; Sang Won YEO ; Byung Do SUH
Korean Journal of Otolaryngology - Head and Neck Surgery 1999;42(5):570-575
BACKGROUND AND OBJECTIVES: Congenital middle ear cholesteatoma (CMEC) is a keratinous mass behind an intact tympanic membrane. CMEC does not have a history of instrumentation and is less common than acquired one. Many theories have been put forward to explain the pathophysiology of CMEC, however, none of these so far have been convincingly proven. This clinical study was performed to investigate the characteristic features of CMEC and to evaluate the correlation between pathophysiology and CMEC by retrospectivly reviewing the cases. MATERIALS AND METHOD: The medical records of patients who underwent otologic procedures at the hospitals of the Catholic university from January 1993 to September 1998 have been reviewed. They were ten males and four females, ranging in age from 4 to 59 (mean age 18). RESULTS: Three of the 14 patients had the lesions isolated to the anterosuperior quadrant of the mesotympanum which were cystic, easily removed and did not affect hearing. The others had more serious condition with extension into the posterior mesotympanum, which were large, often too extensive to indicate a formative site, and causing ossicular damage. CONCLUSION: CMEC presents in two distinctive forms according to the site of formation: the anterosuperior and posterior mesotympanum. The review suggest that the pathophysiology of posterior lesions may be different from anterior ones. For early diagnosis of CMEC, screening program should be carried out in children to prevent the more extensive diseases.
Child
;
Cholesteatoma, Middle Ear*
;
CME-Carbodiimide
;
Ear, Middle*
;
Early Diagnosis
;
Female
;
Hearing
;
Humans
;
Male
;
Mass Screening
;
Medical Records
;
Tympanic Membrane
3.Clinical Outcome of Acute Bacterial Prostatitis, a Multicenter Study.
In Rae CHO ; Keon Cheol LEE ; Seung Eon LEE ; Joon Seong JEON ; Seok San PARK ; Luck Hee SUNG ; Choong Hee NOH ; Won Jae YANG ; Young Deuk CHOI ; Sung Joon HONG ; Seung Choul YANG ; Jin Seon CHO ; Hyun Soo AHN ; Se Joong KIM ; Hong Sup KIM ; Ki Hak SONG ; Do Hwan SEONG ; Jun Kyu SUH ; Kyung Seop LEE ; Yun Seob SONG ; Dong Hyeon LEE ; Young Sig KIM
Korean Journal of Urology 2005;46(10):1034-1039
PURPOSE: Few studies have examined acute prostatitis in Korea. To initiate the investigation of this topic, a multi-center retrospective analysis of acute prostatitis was conducted. MATERIALS AND METHODS: The clinical records of 335 patients from 13 hospitals, diagnosed with acute prostatitis, between January of 1994 and October of 2004, were reviewed. For each patient, the urine culture, changes in the PSA (prostate-specific antigen) value and the prostate volume, the incidence of prostate abscess, the use of antibiotics, and whether the disease went into remission or progressed to chronic prostatitis were analyzed. RESULTS: The mean age of the patients, time from the onset of symptom to admission and number of days of admitted were 54.9+/-15.1 (16-85) years, 2.4+/-3.4 (16-85) days and 7.5+/-3.9 (1-25) days, respectively. The chief symptoms of the patients were high fever, dysuria and urinary frequency. Routine urinalysis found pyuria in 82% and hematuria in 70% of patients. The causative organisms of 43.0% of the patients were cultured, with the chief organisms found to be E. coli (67%) and P. aeruginosa (13%), et al. The mean PSA and prostate volume on initial diagnosis were 24.6+/-30.2ng/ml and 45.8 +/-17.4ml, respectively, and a prostate abscess was found in 4 patients (3.1%). The antibiotics injected during patient admission were: cephalosporin family (68%), aminoglycosides (70%) and quinolone family (43%). An additional alpha blocker was used in 49% of cases. Oral quinolone (91%), cephalosporin (9%) and alpha blocker (44%) were prescribed for a mean 32.5 (2-180) days after discharge. 259 (77%) of the patients were available for follow-up. Of these, 21% took antibiotics over an 8 week treatment period, and 8% over a 12 week period. The disappearance of pyuria after treatment was observed in a mean of 13 days after the end of treatment. After 13 weeks of treatment, 11 (50%) of the 22 patients who received prostate massage (4.2% of all follow up patients) were found to have chronic prostatitis. The mean PSA and prostate volume declined during follow up, to 6.13+/-10.38ng/ml and 37.5+/-13.5ml, respectively. CONCLUSIONS: In our study, the most common chief symptom of acute prostatitis was a high fever, with the most common causative organism being E. coli. Patients were admitted for approximately one week, and treated with antibiotic for about one month, after which time PSA elevation was observed in 80% of patients. Although all acute prostatitis patients were treated with proper antibiotics, progression to chronic prostatitis was observed in 4.2% of patients.
Abscess
;
Aminoglycosides
;
Anti-Bacterial Agents
;
Diagnosis
;
Dysuria
;
Fever
;
Follow-Up Studies
;
Hematuria
;
Humans
;
Incidence
;
Korea
;
Massage
;
Patient Admission
;
Prostate
;
Prostate-Specific Antigen
;
Prostatitis*
;
Pyuria
;
Retrospective Studies
;
Urinalysis